Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212380 | SCV000210882 | benign | not specified | 2014-08-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000160373 | SCV000214470 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001078916 | SCV000637772 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000160373 | SCV000684396 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000555817 | SCV001150956 | likely benign | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000212380 | SCV001362041 | likely benign | not specified | 2020-01-31 | criteria provided, single submitter | clinical testing | |
European Reference Network on Genetic Tumour Risk Syndromes |
RCV001078916 | SCV003926889 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2022-08-01 | criteria provided, single submitter | clinical testing | PS4_Supporting (PMID: 30311375) |
Prevention |
RCV003907492 | SCV004718995 | likely benign | CDH1-related disorder | 2019-07-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |